Doxorubicin bulk supplier for pharma manufacturers

Doxorubicin Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 10 mg/5 mL, 50 mg/25 mL, 200 mg/100 mL (in vials)

Reference Brands: Adriamycin® (EU & US)

Doxorubicin is an intravenous chemotherapy drug used to treat cancers such as breast cancer, leukemia, and lymphomas. Available in 10 mg/5 mL, 50 mg/25 mL, and 200 mg/100 mL vials, it is marketed as Adriamycin® in the US and EU, offering key B2B opportunities in oncology.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Doxorubicin? List it or send an offer →

Product Description: Doxorubicin is a potent chemotherapy drug used to treat a wide range of cancers, including breast cancer, leukemia, and lymphomas. As an anthracycline, it works by inhibiting DNA replication in cancer cells, leading to cell death. Available in 10 mg/5 mL, 50 mg/25 mL, and 200 mg/100 mL vial strengths, Doxorubicin is marketed as Adriamycin® in both the US and EU. With its significant role in cancer treatment, it offers substantial B2B opportunities for pharmaceutical companies targeting oncology treatments in these regions.

Doxorubicin — third party manufacturing & bulk supply

Doxorubicin is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Doxorubicin is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Doxorubicin listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Doxorubicin →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Doxorubicin is listed as Injection in 10 mg/5 mL, 50 mg/25 mL, 200 mg/100 mL (in vials). Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Doxorubicin is referenced against Adriamycin® (EU & US). Reference brands are shown for identification only and remain the property of their respective trademark owners.